Kathleen Tregoning
Directeur/Membre du Conseil chez SPERO THERAPEUTICS, INC.
Fortune : 470 169 $ au 30/04/2024
Postes actifs de Kathleen Tregoning
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Public Communications Contact | 01/07/2020 | - |
| SPERO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/10/2021 | - |
| Independent Dir/Board Member | 11/10/2021 | - |
Historique de carrière de Kathleen Tregoning
Anciens postes connus de Kathleen Tregoning
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SANOFI | Public Communications Contact | 01/02/2017 | 01/03/2020 |
Biogen France SAS
 Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Corporate Officer/Principal | 01/01/2006 | - |
Formation de Kathleen Tregoning
| Stanford University | Undergraduate Degree |
| Harvard Kennedy School of Government | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| France | 3 |
Opérationnelle
| Public Communications Contact | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANOFI | Health Technology |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Health Technology |
- Bourse
- Insiders
- Kathleen Tregoning
- Expérience